ABN AMRO Investment Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Sell |
7,638
-27,102
| -78% | -$14.2M | 0.08% | 186 |
|
|
2025
Q1 | $22M | Sell |
34,740
-2,635
| -7% | -$1.67M | 0.46% | 51 |
|
|
2024
Q4 | $26.6M | Sell |
37,375
-1,725
| -4% | -$1.23M | 0.5% | 57 |
|
|
2024
Q3 | $41.1M | Buy |
39,100
+1,146
| +3% | +$1.2M | 0.72% | 38 |
|
|
2024
Q2 | $39.9M | Sell |
37,954
-2,476
| -6% | -$2.6M | 0.72% | 38 |
|
|
2024
Q1 | $38.9M | Buy |
40,430
+16,081
| +66% | +$15.5M | 0.67% | 41 |
|
|
2023
Q4 | $21.4M | Buy |
24,349
+1,871
| +8% | +$1.64M | 0.38% | 60 |
|
|
2023
Q3 | $18.5M | Buy |
22,478
+460
| +2% | +$379K | 0.36% | 66 |
|
|
2023
Q2 | $15.8M | Buy |
22,018
+4,777
| +28% | +$3.43M | 0.32% | 83 |
|
|
2023
Q1 | $14.2M | Buy |
+17,241
| New | +$14.2M | 0.29% | 90 |
|